1.50Open1.04Pre Close47 Volume2.57K Open Interest77.00Strike Price6.37KTurnover48.01%IV2.19%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry1.50Extrinsic Value100Contract SizeAmericanOptions Type-0.4672Delta0.0984Gamma51.46Leverage Ratio-0.1927Theta-0.0042Rho-24.04Eff Leverage0.0335Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet